| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | olfactory receptor activity | OR51L1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR52L2P OR6Q1 OR52W1 OR52M1 OR52P1 OR52A1 OR51H1 OR52J3 | 6.53e-10 | 431 | 75 | 14 | GO:0004984 |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 1.27e-09 | 14 | 75 | 5 | GO:0005130 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 2.08e-08 | 23 | 75 | 5 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 7.23e-08 | 29 | 75 | 5 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 7.23e-08 | 29 | 75 | 5 | GO:0035325 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.67e-07 | 34 | 75 | 5 | GO:0015125 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR51L1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR52L2P HPGD OR6Q1 OR52W1 OR52M1 OR52P1 OR52A1 OR51H1 OR52J3 | 8.29e-07 | 884 | 75 | 15 | GO:0004930 |
| GeneOntologyMolecularFunction | glycolipid binding | 1.09e-06 | 49 | 75 | 5 | GO:0051861 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 1.45e-06 | 149 | 75 | 7 | GO:1990782 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.38e-06 | 230 | 75 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 6.53e-06 | 70 | 75 | 5 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 8.04e-06 | 73 | 75 | 5 | GO:0170055 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 2.24e-05 | 90 | 75 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 2.42e-05 | 316 | 75 | 8 | GO:0035091 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR51L1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR52L2P HPGD OR6Q1 OR52W1 OR52M1 OR52P1 OR52A1 OR51H1 OR52J3 | 1.29e-04 | 1353 | 75 | 15 | GO:0004888 |
| GeneOntologyMolecularFunction | phosphatase binding | 4.74e-04 | 264 | 75 | 6 | GO:0019902 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 4.87e-04 | 173 | 75 | 5 | GO:0070851 | |
| GeneOntologyMolecularFunction | MAP kinase tyrosine phosphatase activity | 6.14e-04 | 10 | 75 | 2 | GO:0033550 | |
| GeneOntologyMolecularFunction | protein tyrosine/threonine phosphatase activity | 7.49e-04 | 11 | 75 | 2 | GO:0008330 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 8.57e-04 | 196 | 75 | 5 | GO:0005319 | |
| GeneOntologyMolecularFunction | phospholipid binding | 1.03e-03 | 548 | 75 | 8 | GO:0005543 | |
| GeneOntologyMolecularFunction | MAP kinase tyrosine/serine/threonine phosphatase activity | 1.06e-03 | 13 | 75 | 2 | GO:0017017 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.09e-03 | 207 | 75 | 5 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.12e-03 | 208 | 75 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 1.17e-03 | 210 | 75 | 5 | GO:0019903 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 1.37e-03 | 324 | 75 | 6 | GO:0005126 | |
| GeneOntologyMolecularFunction | protein kinase binding | 1.53e-03 | 873 | 75 | 10 | GO:0019901 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.77e-03 | 231 | 75 | 5 | GO:0005085 | |
| GeneOntologyMolecularFunction | MAP kinase phosphatase activity | 2.05e-03 | 18 | 75 | 2 | GO:0033549 | |
| GeneOntologyMolecularFunction | actin binding | 2.13e-03 | 479 | 75 | 7 | GO:0003779 | |
| GeneOntologyMolecularFunction | kinase binding | 3.27e-03 | 969 | 75 | 10 | GO:0019900 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | 3.95e-03 | 25 | 75 | 2 | GO:0016702 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | 4.27e-03 | 26 | 75 | 2 | GO:0016701 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 4.91e-03 | 293 | 75 | 5 | GO:0008514 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 8.52e-03 | 37 | 75 | 2 | GO:0045505 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR51L1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR52L2P OR6Q1 OR52W1 OR52M1 OR52P1 OR52A1 OR51H1 OR52J3 | 4.44e-10 | 432 | 75 | 14 | GO:0050911 |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 1.08e-09 | 14 | 75 | 5 | GO:0070348 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR51L1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR52L2P OR6Q1 OR52W1 OR52M1 OR52P1 OR52A1 OR51H1 OR52J3 | 1.15e-09 | 465 | 75 | 14 | GO:0007608 |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.29e-09 | 31 | 75 | 6 | GO:0010544 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 1.62e-09 | 15 | 75 | 5 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 1.62e-09 | 15 | 75 | 5 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 1.62e-09 | 15 | 75 | 5 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.62e-09 | 15 | 75 | 5 | GO:0002859 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR51L1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR52L2P OR6Q1 OR52W1 OR52M1 OR52P1 OR52A1 OR51H1 OR52J3 | 1.98e-09 | 485 | 75 | 14 | GO:0050907 |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 2.35e-09 | 16 | 75 | 5 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 3.32e-09 | 17 | 75 | 5 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 3.32e-09 | 17 | 75 | 5 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 3.32e-09 | 17 | 75 | 5 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 4.58e-09 | 18 | 75 | 5 | GO:1903385 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR51L1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR52L2P OR6Q1 OR52W1 OR52M1 OR52P1 OR52A1 OR51H1 OR52J3 | 5.32e-09 | 524 | 75 | 14 | GO:0009593 |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 8.25e-09 | 20 | 75 | 5 | GO:2000346 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR51L1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR52L2P OR6Q1 OR52W1 OR52M1 OR52P1 OR52A1 OR51H1 OR52J3 | 9.16e-09 | 547 | 75 | 14 | GO:0007606 |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 1.08e-08 | 21 | 75 | 5 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.08e-08 | 21 | 75 | 5 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.08e-08 | 21 | 75 | 5 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 1.39e-08 | 22 | 75 | 5 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 1.77e-08 | 23 | 75 | 5 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.77e-08 | 23 | 75 | 5 | GO:0002858 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR51L1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR52L2P OR6Q1 OR52W1 OR52M1 OR52P1 OR52A1 OR51H1 OR52J3 | 2.00e-08 | 582 | 75 | 14 | GO:0050906 |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 2.24e-08 | 24 | 75 | 5 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 2.24e-08 | 24 | 75 | 5 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 2.24e-08 | 24 | 75 | 5 | GO:0002420 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 2.70e-08 | 86 | 75 | 7 | GO:0042058 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 2.79e-08 | 25 | 75 | 5 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 2.79e-08 | 25 | 75 | 5 | GO:0002423 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR51L1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR52L2P OR6Q1 OR52W1 OR52M1 OR52P1 TCAP OR52A1 OR51H1 OR52J3 | 4.07e-08 | 722 | 75 | 15 | GO:0051606 |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 4.21e-08 | 27 | 75 | 5 | GO:0070344 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 4.66e-08 | 93 | 75 | 7 | GO:1901184 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 5.11e-08 | 28 | 75 | 5 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 6.16e-08 | 29 | 75 | 5 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 7.29e-08 | 59 | 75 | 6 | GO:0045671 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 8.08e-08 | 60 | 75 | 6 | GO:0045922 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 1.04e-07 | 32 | 75 | 5 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 1.04e-07 | 32 | 75 | 5 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 1.04e-07 | 32 | 75 | 5 | GO:0060312 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 1.22e-07 | 33 | 75 | 5 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 1.22e-07 | 33 | 75 | 5 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 1.42e-07 | 34 | 75 | 5 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 1.42e-07 | 34 | 75 | 5 | GO:0046851 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 1.44e-07 | 66 | 75 | 6 | GO:0010543 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 1.66e-07 | 35 | 75 | 5 | GO:1901142 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 1.89e-07 | 69 | 75 | 6 | GO:0030195 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 2.06e-07 | 70 | 75 | 6 | GO:1900047 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 2.44e-07 | 72 | 75 | 6 | GO:0050819 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 2.54e-07 | 38 | 75 | 5 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 2.90e-07 | 39 | 75 | 5 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 3.31e-07 | 40 | 75 | 5 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 3.76e-07 | 41 | 75 | 5 | GO:0002716 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 4.25e-07 | 42 | 75 | 5 | GO:0090330 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid biosynthetic process | 4.26e-07 | 260 | 75 | 9 | GO:0072330 | |
| GeneOntologyBiologicalProcess | fatty acid biosynthetic process | 4.64e-07 | 191 | 75 | 8 | GO:0006633 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 6.06e-07 | 45 | 75 | 5 | GO:0048521 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 6.57e-07 | 85 | 75 | 6 | GO:0002762 | |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 6.57e-07 | 85 | 75 | 6 | GO:1903670 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 6.77e-07 | 46 | 75 | 5 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 6.77e-07 | 46 | 75 | 5 | GO:0072574 | |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 7.35e-07 | 139 | 75 | 7 | GO:0007173 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 7.54e-07 | 87 | 75 | 6 | GO:0001974 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 7.56e-07 | 47 | 75 | 5 | GO:0001911 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 7.56e-07 | 47 | 75 | 5 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 7.56e-07 | 47 | 75 | 5 | GO:0034104 | |
| GeneOntologyBiologicalProcess | small molecule biosynthetic process | HSD3B7 CAD MBTPS2 ACACB MSMO1 PSG1 PSG3 PSG4 PSG9 GPT ALOXE3 PSG8 ALOX15B | 8.76e-07 | 676 | 75 | 13 | GO:0044283 |
| GeneOntologyBiologicalProcess | liver morphogenesis | 9.35e-07 | 49 | 75 | 5 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 9.35e-07 | 49 | 75 | 5 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 9.84e-07 | 91 | 75 | 6 | GO:0030193 | |
| GeneOntologyBiologicalProcess | carboxylic acid biosynthetic process | 9.91e-07 | 374 | 75 | 10 | GO:0046394 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 1.04e-06 | 50 | 75 | 5 | GO:0002834 | |
| GeneOntologyBiologicalProcess | organic acid biosynthetic process | 1.07e-06 | 377 | 75 | 10 | GO:0016053 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 1.12e-06 | 93 | 75 | 6 | GO:1900046 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 1.26e-06 | 52 | 75 | 5 | GO:0031342 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | 1.35e-06 | 96 | 75 | 6 | GO:0050818 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 1.39e-06 | 53 | 75 | 5 | GO:0034110 | |
| GeneOntologyBiologicalProcess | negative regulation of protein kinase activity | 1.39e-06 | 221 | 75 | 8 | GO:0006469 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 1.52e-06 | 98 | 75 | 6 | GO:0061045 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 1.84e-06 | 56 | 75 | 5 | GO:0002418 | |
| GeneOntologyBiologicalProcess | ERBB signaling pathway | 1.89e-06 | 160 | 75 | 7 | GO:0038127 | |
| GeneOntologyBiologicalProcess | negative regulation of kinase activity | 2.28e-06 | 236 | 75 | 8 | GO:0033673 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 2.55e-06 | 107 | 75 | 6 | GO:0042130 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 2.59e-06 | 60 | 75 | 5 | GO:0030851 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 2.82e-06 | 61 | 75 | 5 | GO:0060259 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 4.08e-06 | 116 | 75 | 6 | GO:0045670 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 4.50e-06 | 67 | 75 | 5 | GO:0045601 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 5.31e-06 | 187 | 75 | 7 | GO:0007156 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 5.59e-06 | 70 | 75 | 5 | GO:0045124 | |
| GeneOntologyBiologicalProcess | sensory perception | OR51L1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR52L2P OR6Q1 ALOXE3 OR52W1 OR52M1 OR52P1 OR52A1 OR51H1 OR52J3 | 5.98e-06 | 1072 | 75 | 15 | GO:0007600 |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 6.00e-06 | 71 | 75 | 5 | GO:0043114 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 6.00e-06 | 71 | 75 | 5 | GO:0002347 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | 6.00e-06 | 124 | 75 | 6 | GO:0050672 | |
| GeneOntologyBiologicalProcess | fatty acid metabolic process | 6.38e-06 | 461 | 75 | 10 | GO:0006631 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 6.43e-06 | 72 | 75 | 5 | GO:0032692 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 6.58e-06 | 126 | 75 | 6 | GO:1903035 | |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | 6.58e-06 | 126 | 75 | 6 | GO:0032945 | |
| GeneOntologyBiologicalProcess | negative regulation of transferase activity | 6.66e-06 | 273 | 75 | 8 | GO:0051348 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 6.88e-06 | 73 | 75 | 5 | GO:0042304 | |
| GeneOntologyBiologicalProcess | lipoxygenase pathway | 7.46e-06 | 11 | 75 | 3 | GO:0019372 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 2.35e-09 | 16 | 76 | 5 | GO:0070021 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 1.92e-05 | 90 | 76 | 5 | GO:0016328 | |
| GeneOntologyCellularComponent | ciliary membrane | 2.90e-05 | 98 | 76 | 5 | GO:0060170 | |
| GeneOntologyCellularComponent | adherens junction | 1.23e-04 | 212 | 76 | 6 | GO:0005912 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 2.70e-04 | 157 | 76 | 5 | GO:1902554 | |
| GeneOntologyCellularComponent | T cell receptor complex | 3.20e-04 | 163 | 76 | 5 | GO:0042101 | |
| GeneOntologyCellularComponent | protein kinase complex | 3.89e-04 | 170 | 76 | 5 | GO:1902911 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.09e-03 | 320 | 76 | 6 | GO:0016323 | |
| GeneOntologyCellularComponent | cell-cell junction | 1.36e-03 | 591 | 76 | 8 | GO:0005911 | |
| GeneOntologyCellularComponent | basal plasma membrane | 1.83e-03 | 354 | 76 | 6 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 2.53e-03 | 378 | 76 | 6 | GO:0045178 | |
| HumanPheno | Aplasia/Hypoplasia of the bladder | 2.81e-05 | 16 | 20 | 3 | HP:0010476 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 1.79e-09 | 35 | 48 | 6 | MP:0031618 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 2.31e-09 | 17 | 48 | 5 | MP:0031047 | |
| MousePheno | decreased muscle cell glucose uptake | 3.55e-09 | 39 | 48 | 6 | MP:0030022 | |
| MousePheno | increased skeletal muscle triglyceride level | 7.52e-09 | 21 | 48 | 5 | MP:0031415 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 1.14e-08 | 47 | 48 | 6 | MP:0031617 | |
| MousePheno | decreased fatty acid oxidation | 1.56e-08 | 24 | 48 | 5 | MP:0014172 | |
| MousePheno | decreased cellular glucose uptake | 2.41e-08 | 53 | 48 | 6 | MP:0003926 | |
| MousePheno | abnormal fatty acid oxidation | 2.70e-08 | 54 | 48 | 6 | MP:0010953 | |
| MousePheno | increased abdominal fat pad weight | 2.94e-08 | 27 | 48 | 5 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 3.57e-08 | 28 | 48 | 5 | MP:0020950 | |
| MousePheno | abnormal lipid oxidation | 5.71e-08 | 61 | 48 | 6 | MP:0010951 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 6.12e-08 | 31 | 48 | 5 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 6.12e-08 | 31 | 48 | 5 | MP:0008964 | |
| MousePheno | increased insulin secretion | 7.65e-08 | 64 | 48 | 6 | MP:0003058 | |
| MousePheno | decreased respiratory quotient | 8.70e-08 | 110 | 48 | 7 | MP:0010379 | |
| MousePheno | abnormal muscle cell glucose uptake | 1.01e-07 | 67 | 48 | 6 | MP:0004130 | |
| MousePheno | abnormal muscle triglyceride level | 1.34e-07 | 36 | 48 | 5 | MP:0031412 | |
| MousePheno | abnormal vascular wound healing | 1.70e-07 | 73 | 48 | 6 | MP:0004883 | |
| MousePheno | polyphagia | 2.94e-07 | 80 | 48 | 6 | MP:0001433 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 3.78e-07 | 44 | 48 | 5 | MP:0031023 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 6.56e-07 | 49 | 48 | 5 | MP:0020948 | |
| MousePheno | abnormal cellular glucose uptake | 1.25e-06 | 102 | 48 | 6 | MP:0003925 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 1.83e-06 | 60 | 48 | 5 | MP:0009790 | |
| MousePheno | abnormal respiratory quotient | 2.29e-06 | 178 | 48 | 7 | MP:0004129 | |
| MousePheno | decreased triglyceride level | 2.36e-06 | 348 | 48 | 9 | MP:0005318 | |
| MousePheno | increased triglyceride level | 2.71e-06 | 354 | 48 | 9 | MP:0005317 | |
| MousePheno | abnormal carbon dioxide production | 3.17e-06 | 67 | 48 | 5 | MP:0008962 | |
| MousePheno | decreased circulating triglyceride level | 3.86e-06 | 275 | 48 | 8 | MP:0002644 | |
| MousePheno | increased circulating leptin level | 4.09e-06 | 125 | 48 | 6 | MP:0005669 | |
| MousePheno | insulin resistance | 4.48e-06 | 197 | 48 | 7 | MP:0005331 | |
| MousePheno | increased circulating insulin level | 4.78e-06 | 283 | 48 | 8 | MP:0002079 | |
| MousePheno | abnormal skeletal muscle morphology | 6.93e-06 | 508 | 48 | 10 | MP:0000759 | |
| MousePheno | decreased oxygen consumption | 7.18e-06 | 79 | 48 | 5 | MP:0005290 | |
| MousePheno | abnormal circulating triglyceride level | 7.95e-06 | 516 | 48 | 10 | MP:0011969 | |
| MousePheno | decreased susceptibility to Riboviria infection | 8.63e-06 | 82 | 48 | 5 | MP:0020914 | |
| MousePheno | abnormal glycogen homeostasis | 9.25e-06 | 144 | 48 | 6 | MP:0005438 | |
| MousePheno | abnormal circulating leptin level | 1.46e-05 | 236 | 48 | 7 | MP:0005667 | |
| MousePheno | abnormal insulin secretion | 2.46e-05 | 171 | 48 | 6 | MP:0003564 | |
| MousePheno | decreased lipid level | DENND5B HSD3B7 ACACB PSG1 PSG3 PSG4 PSG9 DUSP7 BAG3 PSG8 NOS3 | 2.69e-05 | 727 | 48 | 11 | MP:0014461 |
| MousePheno | abnormal abdominal fat pad morphology | 2.86e-05 | 262 | 48 | 7 | MP:0000010 | |
| MousePheno | abnormal endocrine pancreas secretion | 2.89e-05 | 176 | 48 | 6 | MP:0014195 | |
| MousePheno | cryptophthalmos | 3.46e-05 | 3 | 48 | 2 | MP:0005242 | |
| MousePheno | abnormal pancreas secretion | 3.60e-05 | 183 | 48 | 6 | MP:0002694 | |
| MousePheno | abnormal susceptibility to Riboviria infection | 3.95e-05 | 186 | 48 | 6 | MP:0020912 | |
| MousePheno | obese | 4.10e-05 | 113 | 48 | 5 | MP:0001261 | |
| MousePheno | abnormal susceptibility to viral infection | 4.28e-05 | 279 | 48 | 7 | MP:0020185 | |
| MousePheno | increased food intake | 4.32e-05 | 189 | 48 | 6 | MP:0011939 | |
| MousePheno | abnormal circulating insulin level | 4.65e-05 | 505 | 48 | 9 | MP:0001560 | |
| MousePheno | abnormal wound healing | 4.85e-05 | 193 | 48 | 6 | MP:0005023 | |
| MousePheno | abnormal triglyceride level | 5.02e-05 | 639 | 48 | 10 | MP:0000187 | |
| MousePheno | abnormal oxygen consumption | 5.14e-05 | 195 | 48 | 6 | MP:0005288 | |
| MousePheno | increased hormone level | 5.16e-05 | 641 | 48 | 10 | MP:0014454 | |
| MousePheno | abnormal blood vessel physiology | 5.21e-05 | 394 | 48 | 8 | MP:0000249 | |
| MousePheno | decreased energy expenditure | 5.25e-05 | 119 | 48 | 5 | MP:0004890 | |
| MousePheno | abnormal pancreatic beta cell physiology | 5.29e-05 | 196 | 48 | 6 | MP:0003562 | |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 5.47e-05 | 120 | 48 | 5 | MP:0009786 | |
| MousePheno | abnormal vasculature physiology | 6.22e-05 | 404 | 48 | 8 | MP:0031170 | |
| MousePheno | abnormal endocrine pancreas physiology | 6.26e-05 | 202 | 48 | 6 | MP:0010147 | |
| MousePheno | decreased susceptibility to viral infection | 6.64e-05 | 125 | 48 | 5 | MP:0002410 | |
| MousePheno | abnormal muscle physiology | ARFGEF3 OR51E1 PSG1 PSG3 PSG4 PSG9 BAG3 ALPK3 PSG8 PRDM4 TCAP NOS3 | 6.69e-05 | 954 | 48 | 12 | MP:0002106 |
| MousePheno | abnormal fat pad morphology | 9.01e-05 | 314 | 48 | 7 | MP:0005334 | |
| MousePheno | increased incidence of tumors by chemical induction | 1.17e-04 | 141 | 48 | 5 | MP:0004499 | |
| MousePheno | increased circulating hormone level | 1.31e-04 | 578 | 48 | 9 | MP:0014456 | |
| MousePheno | abnormal colon morphology | 1.67e-04 | 152 | 48 | 5 | MP:0000495 | |
| MousePheno | abnormal susceptibility to induced aneurysm formation | 1.72e-04 | 6 | 48 | 2 | MP:0031272 | |
| MousePheno | abnormal gas homeostasis | 1.74e-04 | 600 | 48 | 9 | MP:0003948 | |
| MousePheno | increased lean body mass | 1.90e-04 | 354 | 48 | 7 | MP:0003960 | |
| MousePheno | impaired glucose tolerance | 2.05e-04 | 480 | 48 | 8 | MP:0005293 | |
| MousePheno | microphthalmia | 2.17e-04 | 362 | 48 | 7 | MP:0001297 | |
| MousePheno | increased total tissue mass | 2.25e-04 | 364 | 48 | 7 | MP:0012323 | |
| MousePheno | increased body weight | 2.25e-04 | 364 | 48 | 7 | MP:0001260 | |
| MousePheno | abnormal eye size | 2.70e-04 | 375 | 48 | 7 | MP:0002697 | |
| MousePheno | abnormal muscle morphology | FREM2 ACACB PSG1 PSG3 PSG4 PSG9 BAG3 ALPK3 PSG8 TCAP NOS3 FREM1 | 2.72e-04 | 1106 | 48 | 12 | MP:0002108 |
| MousePheno | abnormal glucose tolerance | 2.80e-04 | 787 | 48 | 10 | MP:0005291 | |
| MousePheno | abnormal incidence of induced tumors | 2.99e-04 | 269 | 48 | 6 | MP:0013151 | |
| MousePheno | increased incidence of induced tumors | 3.05e-04 | 173 | 48 | 5 | MP:0002021 | |
| MousePheno | abnormal large intestine morphology | 3.43e-04 | 276 | 48 | 6 | MP:0000489 | |
| MousePheno | abnormal susceptibility to infection induced morbidity/mortality | 3.64e-04 | 279 | 48 | 6 | MP:0009785 | |
| MousePheno | abnormal susceptibility to infection | 4.04e-04 | 672 | 48 | 9 | MP:0001793 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 4.15e-04 | 286 | 48 | 6 | MP:0008873 | |
| MousePheno | increased body size | 4.55e-04 | 409 | 48 | 7 | MP:0001264 | |
| MousePheno | increased cardiomyocyte apoptosis | 4.56e-04 | 44 | 48 | 3 | MP:0003222 | |
| MousePheno | abnormal pancreas physiology | 4.63e-04 | 292 | 48 | 6 | MP:0002693 | |
| MousePheno | abnormal response to infection | 6.27e-04 | 714 | 48 | 9 | MP:0005025 | |
| MousePheno | abnormal energy expenditure | 6.68e-04 | 313 | 48 | 6 | MP:0005450 | |
| MousePheno | abnormal response to antigen | 7.07e-04 | 726 | 48 | 9 | MP:0020000 | |
| MousePheno | absent eyelids | 7.45e-04 | 12 | 48 | 2 | MP:0001341 | |
| MousePheno | abnormal energy homeostasis | 7.74e-04 | 322 | 48 | 6 | MP:0005448 | |
| MousePheno | abnormal cardiomyocyte apoptosis | 7.89e-04 | 53 | 48 | 3 | MP:0003221 | |
| MousePheno | abnormal hormone level | ARFGEF3 ACACB PSG1 PSG3 ARHGEF10 PSG4 PSG9 HPGD BAG3 PSG8 NOS3 | 8.32e-04 | 1073 | 48 | 11 | MP:0003953 |
| MousePheno | bleb | 8.79e-04 | 13 | 48 | 2 | MP:0008854 | |
| MousePheno | increased circulating progesterone level | 1.18e-03 | 15 | 48 | 2 | MP:0005186 | |
| MousePheno | abnormal food intake | 1.19e-03 | 481 | 48 | 7 | MP:0005449 | |
| MousePheno | abnormal circulating hormone level | 1.26e-03 | 954 | 48 | 10 | MP:0005418 | |
| MousePheno | abnormal endocrine gland physiology | 1.44e-03 | 363 | 48 | 6 | MP:0013561 | |
| MousePheno | abnormal macrophage activation involved in immune response | 1.52e-03 | 17 | 48 | 2 | MP:0011075 | |
| MousePheno | decreased susceptibility to infection | 1.75e-03 | 255 | 48 | 5 | MP:0002409 | |
| MousePheno | increased lipid level | 2.09e-03 | 847 | 48 | 9 | MP:0014460 | |
| MousePheno | abnormal gland physiology | 2.23e-03 | 691 | 48 | 8 | MP:0002164 | |
| MousePheno | abnormal heart valve morphology | 2.33e-03 | 163 | 48 | 4 | MP:0000285 | |
| Domain | Olfact_rcpt | OR51L1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR6Q1 OR52W1 OR52M1 OR52A1 OR52J3 | 3.44e-07 | 393 | 73 | 11 | IPR000725 |
| Domain | Ig_2 | 4.00e-07 | 73 | 73 | 6 | PF13895 | |
| Domain | IGc2 | 3.67e-05 | 235 | 73 | 7 | SM00408 | |
| Domain | Ig_sub2 | 3.67e-05 | 235 | 73 | 7 | IPR003598 | |
| Domain | GPCR_Rhodpsn_7TM | OR51L1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR6Q1 OR52W1 OR52M1 OR52A1 OR52J3 | 5.48e-05 | 670 | 73 | 11 | IPR017452 |
| Domain | 7tm_1 | OR51L1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR6Q1 OR52W1 OR52M1 OR52A1 OR52J3 | 6.02e-05 | 677 | 73 | 11 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR51L1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR6Q1 OR52W1 OR52M1 OR52A1 OR52J3 | 6.69e-05 | 685 | 73 | 11 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR51L1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR6Q1 OR52W1 OR52M1 OR52A1 OR52J3 | 7.23e-05 | 691 | 73 | 11 | PS50262 |
| Domain | PLAT | 7.24e-05 | 21 | 73 | 3 | PS50095 | |
| Domain | - | 7.24e-05 | 21 | 73 | 3 | 2.60.60.20 | |
| Domain | PLAT | 7.24e-05 | 21 | 73 | 3 | PF01477 | |
| Domain | PLAT/LH2_dom | 7.24e-05 | 21 | 73 | 3 | IPR001024 | |
| Domain | GPCR_Rhodpsn | OR51L1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR6Q1 OR52W1 OR52M1 OR52A1 OR52J3 | 7.33e-05 | 692 | 73 | 11 | IPR000276 |
| Domain | V-set | 8.30e-05 | 184 | 73 | 6 | PF07686 | |
| Domain | ig | 9.90e-05 | 190 | 73 | 6 | PF00047 | |
| Domain | Immunoglobulin | 9.90e-05 | 190 | 73 | 6 | IPR013151 | |
| Domain | Ig_V-set | 1.28e-04 | 199 | 73 | 6 | IPR013106 | |
| Domain | CPSASE_1 | 1.50e-04 | 5 | 73 | 2 | PS00866 | |
| Domain | - | 2.24e-04 | 6 | 73 | 2 | 2.40.50.90 | |
| Domain | LipOase_mml | 2.24e-04 | 6 | 73 | 2 | IPR001885 | |
| Domain | LIPOXYGENASE_1 | 2.24e-04 | 6 | 73 | 2 | PS00711 | |
| Domain | LipOase_C | 2.24e-04 | 6 | 73 | 2 | IPR013819 | |
| Domain | Lipoxygenase | 2.24e-04 | 6 | 73 | 2 | PF00305 | |
| Domain | CPSASE_2 | 2.24e-04 | 6 | 73 | 2 | PS00867 | |
| Domain | Staphylococal_nuclease_OB-fold | 2.24e-04 | 6 | 73 | 2 | IPR016071 | |
| Domain | LIPOXYGENASE_3 | 2.24e-04 | 6 | 73 | 2 | PS51393 | |
| Domain | LIPOXYGENASE_2 | 2.24e-04 | 6 | 73 | 2 | PS00081 | |
| Domain | LipOase | 2.24e-04 | 6 | 73 | 2 | IPR000907 | |
| Domain | LipOase_Fe_BS | 2.24e-04 | 6 | 73 | 2 | IPR020833 | |
| Domain | LipOase_CS | 2.24e-04 | 6 | 73 | 2 | IPR020834 | |
| Domain | CPSase_L_D2 | 3.12e-04 | 7 | 73 | 2 | PF02786 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 3.12e-04 | 7 | 73 | 2 | IPR005479 | |
| Domain | BC-like_N | 3.12e-04 | 7 | 73 | 2 | IPR005481 | |
| Domain | Biotin_carb_N | 3.12e-04 | 7 | 73 | 2 | PF00289 | |
| Domain | Calx_beta | 5.33e-04 | 9 | 73 | 2 | IPR003644 | |
| Domain | Calx-beta | 5.33e-04 | 9 | 73 | 2 | PF03160 | |
| Domain | MKP | 6.64e-04 | 10 | 73 | 2 | IPR008343 | |
| Domain | - | 1.14e-03 | 13 | 73 | 2 | 3.40.50.20 | |
| Domain | Cadherin | 1.18e-03 | 118 | 73 | 4 | IPR002126 | |
| Domain | IG | 1.27e-03 | 421 | 73 | 7 | SM00409 | |
| Domain | Ig_sub | 1.27e-03 | 421 | 73 | 7 | IPR003599 | |
| Domain | TUDOR | 1.33e-03 | 14 | 73 | 2 | PF00567 | |
| Domain | ATP-grasp | 1.33e-03 | 14 | 73 | 2 | IPR011761 | |
| Domain | PreATP-grasp_dom | 1.33e-03 | 14 | 73 | 2 | IPR016185 | |
| Domain | uDENN | 1.33e-03 | 14 | 73 | 2 | SM00800 | |
| Domain | ATP_GRASP | 1.33e-03 | 14 | 73 | 2 | PS50975 | |
| Domain | uDENN | 1.53e-03 | 15 | 73 | 2 | PF03456 | |
| Domain | - | 1.53e-03 | 15 | 73 | 2 | 3.30.1490.20 | |
| Domain | UDENN | 1.75e-03 | 16 | 73 | 2 | PS50946 | |
| Domain | DDENN | 1.75e-03 | 16 | 73 | 2 | PS50947 | |
| Domain | DENN | 1.75e-03 | 16 | 73 | 2 | SM00799 | |
| Domain | dDENN | 1.75e-03 | 16 | 73 | 2 | SM00801 | |
| Domain | DENN | 1.75e-03 | 16 | 73 | 2 | PF02141 | |
| Domain | dDENN_dom | 1.75e-03 | 16 | 73 | 2 | IPR005112 | |
| Domain | uDENN_dom | 1.75e-03 | 16 | 73 | 2 | IPR005113 | |
| Domain | dDENN | 1.75e-03 | 16 | 73 | 2 | PF03455 | |
| Domain | DENN | 1.75e-03 | 16 | 73 | 2 | PS50211 | |
| Domain | DENN_dom | 1.75e-03 | 16 | 73 | 2 | IPR001194 | |
| Domain | LH2 | 2.21e-03 | 18 | 73 | 2 | SM00308 | |
| Domain | ATP_grasp_subdomain_1 | 2.21e-03 | 18 | 73 | 2 | IPR013815 | |
| Domain | - | 2.21e-03 | 18 | 73 | 2 | 3.30.470.20 | |
| Domain | IG_LIKE | 3.04e-03 | 491 | 73 | 7 | PS50835 | |
| Domain | RHOD | 3.31e-03 | 22 | 73 | 2 | SM00450 | |
| Domain | Ig-like_dom | 3.47e-03 | 503 | 73 | 7 | IPR007110 | |
| Domain | RHODANESE_3 | 3.61e-03 | 23 | 73 | 2 | PS50206 | |
| Domain | TUDOR | 3.61e-03 | 23 | 73 | 2 | PS50304 | |
| Domain | Rhodanese-like_dom | 3.93e-03 | 24 | 73 | 2 | IPR001763 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR51L1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR6Q1 OR52W1 OR52M1 OR52A1 OR51H1 OR52J3 | 1.80e-07 | 417 | 61 | 12 | M4072 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR51L1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR6Q1 OR52W1 OR52M1 OR52A1 OR52J3 | 7.43e-07 | 389 | 61 | 11 | M14091 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR51L1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR6Q1 OR52W1 OR52M1 OR52A1 OR51H1 OR52J3 | 1.46e-05 | 636 | 61 | 12 | M41834 |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 6.72e-05 | 99 | 61 | 5 | MM14624 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 1.57e-04 | 188 | 61 | 6 | MM15828 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.86e-04 | 194 | 61 | 6 | M16312 | |
| Pubmed | OR51L1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR52L2P OR6Q1 OR52W1 OR52M1 OR52P1 OR52A1 OR51H1 OR52J3 | 1.69e-11 | 541 | 78 | 14 | 14983052 | |
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 6.32e-11 | 13 | 78 | 5 | 34058224 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 6.32e-11 | 13 | 78 | 5 | 1985902 | |
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 10964771 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 32169849 | ||
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 6.32e-11 | 13 | 78 | 5 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 6.32e-11 | 13 | 78 | 5 | 16638824 | |
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 20044046 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 32150576 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 22469976 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 6265583 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 6.32e-11 | 13 | 78 | 5 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 6.32e-11 | 13 | 78 | 5 | 28035001 | |
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 6.32e-11 | 13 | 78 | 5 | 12832451 | |
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 25406283 | ||
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 6.32e-11 | 13 | 78 | 5 | 15316023 | |
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 6.32e-11 | 13 | 78 | 5 | 21670291 | |
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 22162753 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 6.32e-11 | 13 | 78 | 5 | 23935487 | |
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 2702644 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 8380065 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 1279194 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 15331748 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 6.32e-11 | 13 | 78 | 5 | 22406619 | |
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 7628460 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 25724769 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 26374765 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 6.32e-11 | 13 | 78 | 5 | 25972571 | |
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 6.32e-11 | 13 | 78 | 5 | 22092845 | |
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 11801635 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 28913658 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 19008452 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 6.32e-11 | 13 | 78 | 5 | 15220458 | |
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 6.32e-11 | 13 | 78 | 5 | 8500759 | |
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 18843289 | ||
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 6.32e-11 | 13 | 78 | 5 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 6.32e-11 | 13 | 78 | 5 | 23800882 | |
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 15207636 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 19285068 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 21760897 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 6.32e-11 | 13 | 78 | 5 | 1326665 | |
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 21081647 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 11133662 | ||
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 6.32e-11 | 13 | 78 | 5 | 39168268 | |
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 11483763 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 8402684 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 2164599 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 16619040 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 6.32e-11 | 13 | 78 | 5 | 8209741 | |
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 6.32e-11 | 13 | 78 | 5 | 21949477 | |
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 29396368 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 26219866 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 18003729 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 26284027 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 2133556 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 32521208 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 6.32e-11 | 13 | 78 | 5 | 33352461 | |
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 19406938 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 38381498 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 20739537 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 6.32e-11 | 13 | 78 | 5 | 29967450 | |
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 1633107 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 6.32e-11 | 13 | 78 | 5 | 19358828 | |
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 6.32e-11 | 13 | 78 | 5 | 27695943 | |
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 20404914 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 16680193 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 26911181 | ||
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 1653760 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 6.32e-11 | 13 | 78 | 5 | 32027621 | |
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 6.32e-11 | 13 | 78 | 5 | 27777319 | |
| Pubmed | 6.32e-11 | 13 | 78 | 5 | 18848945 | ||
| Pubmed | 9.81e-11 | 14 | 78 | 5 | 37531413 | ||
| Pubmed | 9.81e-11 | 14 | 78 | 5 | 23780386 | ||
| Pubmed | 9.81e-11 | 14 | 78 | 5 | 28567513 | ||
| Pubmed | 9.81e-11 | 14 | 78 | 5 | 8207827 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 9.81e-11 | 14 | 78 | 5 | 34666041 | |
| Pubmed | 9.81e-11 | 14 | 78 | 5 | 19700760 | ||
| Pubmed | 9.81e-11 | 14 | 78 | 5 | 34619794 | ||
| Pubmed | Expression patterns of CD66a and CD117 in the mouse submandibular gland. | 9.81e-11 | 14 | 78 | 5 | 25498293 | |
| Pubmed | Endothelial barrier function is differentially regulated by CEACAM1-mediated signaling. | 9.81e-11 | 14 | 78 | 5 | 29746166 | |
| Pubmed | 9.81e-11 | 14 | 78 | 5 | 9212243 | ||
| Pubmed | CEACAM1 controls the EMT switch in murine mammary carcinoma in vitro and in vivo. | 9.81e-11 | 14 | 78 | 5 | 27572314 | |
| Pubmed | 9.81e-11 | 14 | 78 | 5 | 1648219 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 9.81e-11 | 14 | 78 | 5 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 9.81e-11 | 14 | 78 | 5 | 32209360 | |
| Pubmed | 9.81e-11 | 14 | 78 | 5 | 11994468 | ||
| Pubmed | 9.81e-11 | 14 | 78 | 5 | 11850617 | ||
| Pubmed | CEACAM2 positively regulates integrin αIIbβ3-mediated platelet functions. | 9.81e-11 | 14 | 78 | 5 | 27161904 | |
| Pubmed | 9.81e-11 | 14 | 78 | 5 | 20381490 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 9.81e-11 | 14 | 78 | 5 | 26196244 | |
| Pubmed | 9.81e-11 | 14 | 78 | 5 | 8896983 | ||
| Pubmed | 9.81e-11 | 14 | 78 | 5 | 22962327 | ||
| Interaction | PSG4 interactions | 8.21e-09 | 8 | 68 | 4 | int:PSG4 | |
| Interaction | PSG1 interactions | 7.84e-07 | 51 | 68 | 5 | int:PSG1 | |
| Interaction | PSG3 interactions | 8.28e-07 | 22 | 68 | 4 | int:PSG3 | |
| Interaction | PSG8 interactions | 1.09e-05 | 41 | 68 | 4 | int:PSG8 | |
| Interaction | PSG9 interactions | 5.40e-05 | 22 | 68 | 3 | int:PSG9 | |
| Cytoband | 11p15.4 | OR51L1 DNHD1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR52L2P SBF2 OR52W1 OR52M1 OR52P1 OR51H1 OR52J3 | 4.48e-19 | 200 | 78 | 14 | 11p15.4 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | OR51L1 DNHD1 OR51T1 OR51E1 OR52R1 OR51D1 OR52A5 OR52L2P SBF2 OR52W1 OR52M1 OR52P1 OR52A1 E2F8 OR51H1 OR52J3 | 1.86e-15 | 564 | 78 | 16 | chr11p15 |
| Cytoband | 19q13.2 | 3.94e-07 | 164 | 78 | 6 | 19q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p13 | 3.71e-03 | 53 | 78 | 2 | chr7p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 4.17e-03 | 1192 | 78 | 7 | chr19q13 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 4.24e-13 | 11 | 59 | 6 | 1315 | |
| GeneFamily | Olfactory receptors, family 52 | 3.19e-12 | 49 | 59 | 8 | 165 | |
| GeneFamily | Olfactory receptors, family 51 | 3.07e-07 | 44 | 59 | 5 | 164 | |
| GeneFamily | Arachidonate lipoxygenases | 1.56e-04 | 6 | 59 | 2 | 407 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.89e-04 | 163 | 59 | 5 | 590 | |
| GeneFamily | MAP kinase phosphatases | 5.65e-04 | 11 | 59 | 2 | 895 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 2.99e-03 | 25 | 59 | 2 | 504 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 4.58e-03 | 31 | 59 | 2 | 81 | |
| GeneFamily | Tudor domain containing | 6.48e-03 | 37 | 59 | 2 | 780 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 4.99e-09 | 48 | 75 | 6 | MM531 | |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_UP | 1.75e-08 | 102 | 75 | 7 | M10290 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 3.18e-08 | 32 | 75 | 5 | MM2 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 5.09e-08 | 35 | 75 | 5 | MM757 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 2.80e-07 | 93 | 75 | 6 | M40279 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 2.47e-06 | 75 | 75 | 5 | MM605 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 3.17e-06 | 219 | 75 | 7 | MM3826 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_DN | 4.27e-06 | 436 | 75 | 9 | MM1326 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 5.16e-06 | 87 | 75 | 5 | MM851 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 1.40e-05 | 182 | 75 | 6 | MM993 | |
| Coexpression | SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 | 2.19e-05 | 197 | 75 | 6 | M12824 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 2.45e-05 | 201 | 75 | 6 | MM1294 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 3.37e-05 | 128 | 75 | 5 | MM1000 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 4.35e-05 | 135 | 75 | 5 | MM965 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS | 4.49e-05 | 224 | 75 | 6 | M40145 | |
| Coexpression | KUMAR_TARGETS_OF_MLL_AF9_FUSION | 5.35e-05 | 463 | 75 | 8 | MM1011 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 5.72e-05 | 143 | 75 | 5 | MM989 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 9.45e-05 | 159 | 75 | 5 | MM760 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | 1.14e-04 | 822 | 75 | 10 | M6782 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 1.65e-04 | 284 | 75 | 6 | MM987 | |
| Coexpression | GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP | 2.23e-04 | 191 | 75 | 5 | M4722 | |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | 2.30e-04 | 302 | 75 | 6 | MM16604 | |
| Coexpression | GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP | 2.45e-04 | 195 | 75 | 5 | M7706 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | 2.61e-04 | 741 | 75 | 9 | MM1037 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN | 2.75e-04 | 200 | 75 | 5 | M5980 | |
| Coexpression | GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_UP | 2.75e-04 | 200 | 75 | 5 | M6955 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 2.82e-04 | 201 | 75 | 5 | MM1006 | |
| CoexpressionAtlas | placenta | 1.10e-05 | 349 | 65 | 8 | placenta | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.89e-06 | 136 | 77 | 5 | 2c723777fadc5946df67d3e992471d8134b827f4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_low-phase|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-06 | 138 | 77 | 5 | cd2f4682fcfd0275ce0640150bbb18da839e5c0a | |
| Computational | Neighborhood of CDKN1C | 5.40e-08 | 27 | 42 | 5 | GNF2_CDKN1C | |
| Computational | Neighborhood of EGFR | 1.33e-07 | 32 | 42 | 5 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 2.12e-07 | 35 | 42 | 5 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 5.45e-07 | 42 | 42 | 5 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 8.68e-07 | 46 | 42 | 5 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 1.20e-06 | 49 | 42 | 5 | GNF2_KISS1 | |
| Computational | Genes in the cancer module 326. | 1.13e-03 | 13 | 42 | 2 | MODULE_326 | |
| Computational | Genes in the cancer module 148. | 1.13e-03 | 13 | 42 | 2 | MODULE_148 | |
| Computational | Eicosanoid metabolism (and related carboxylic acid biosynthesis). | 1.52e-03 | 15 | 42 | 2 | MODULE_462 | |
| Drug | AC1L1IPV | 5.31e-09 | 43 | 74 | 6 | CID000004683 | |
| Drug | Yohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; HL60; HG-U133A | 3.60e-06 | 197 | 74 | 7 | 1763_UP | |
| Drug | 13-HPODE | 4.28e-06 | 74 | 74 | 5 | CID000001426 | |
| Drug | Rgd Peptide | 1.27e-05 | 239 | 74 | 7 | CID000104802 | |
| Disease | cD177 antigen measurement | 5.05e-10 | 18 | 69 | 5 | EFO_0021866 | |
| Disease | Marles Greenberg Persaud syndrome | 5.39e-06 | 2 | 69 | 2 | C1855425 | |
| Disease | pregnancy-specific beta-1-glycoprotein 9 measurement | 3.22e-05 | 4 | 69 | 2 | EFO_0801909 | |
| Disease | Fraser syndrome (implicated_via_orthology) | 3.22e-05 | 4 | 69 | 2 | DOID:0090001 (implicated_via_orthology) | |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 8.03e-05 | 6 | 69 | 2 | EFO_0801907 | |
| Disease | Unilateral agenesis of kidney | 1.50e-04 | 8 | 69 | 2 | C0266294 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 4.76e-04 | 276 | 69 | 5 | EFO_0004612, EFO_0020943 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 5.74e-04 | 69 | 69 | 3 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | familial hyperlipidemia (biomarker_via_orthology) | 8.98e-04 | 19 | 69 | 2 | DOID:1168 (biomarker_via_orthology) | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 1.44e-03 | 24 | 69 | 2 | DOID:3827 (biomarker_via_orthology) | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.90e-03 | 224 | 69 | 4 | EFO_0004574, EFO_0008317 | |
| Disease | Primary familial dilated cardiomyopathy | 2.25e-03 | 30 | 69 | 2 | cv:C0340427 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GVLIPIPQYPLYSAT | 181 | P24298 | |
| GYAVPSNLPLLLPAY | 156 | O15013 | |
| DLLDYTYPLRPGPQL | 301 | Q76N32 | |
| PLVLYAPLLNPYTLA | 311 | Q9H2F3 | |
| PEIIPLYLIYRPANN | 1701 | Q96L96 | |
| LLDYGYPLMPTPTLL | 51 | Q3C1V8 | |
| YEYLGPRLGPLPSLL | 1651 | Q96M86 | |
| YIPLISLPLVPGFPY | 256 | O43251 | |
| YLQKPGQPPQLLIYE | 61 | A0A075B6S2 | |
| GLRQYKQPILIYIPP | 2181 | O00763 | |
| YDIPLNPLNLIPFYA | 231 | Q15800 | |
| LEIPFDPAIPLLGIY | 1166 | O00370 | |
| YLLLPPALNPLIYGA | 286 | Q6IF63 | |
| SYPYIPILPAQLLEV | 251 | Q86WG5 | |
| QGLALPYTYLDPPLI | 691 | Q9BYJ1 | |
| ALPRYGELLHYPQVP | 226 | Q5SZK8 | |
| PPYILDILPDTYQHL | 71 | Q13191 | |
| PVYDQGGPVEILPYL | 166 | Q05923 | |
| LGVILYILLSGYPPF | 281 | Q9HBH9 | |
| TYLLLPPVVNPLVYG | 291 | Q8NGF3 | |
| YLLVPPVLNPIVYGV | 281 | Q8TCB6 | |
| DIYLLLPPVLNPIVY | 281 | Q8NH63 | |
| IYLLLPPVLNPIVYS | 281 | Q8NGJ5 | |
| IYLLLPPVLNPIIYS | 281 | Q8NGJ9 | |
| SIYLLVPPFLNPLVY | 281 | Q9UKL2 | |
| NLYLLVPPFLNPIVY | 281 | Q9H2C5 | |
| EIGVPLYQSPPGRYL | 1046 | O95206 | |
| PEELLYVITSPPRYG | 1426 | Q5H8C1 | |
| LMPVLGYDPPQLYLT | 1046 | Q9H6R4 | |
| ILPIYLLSQLTFYGP | 161 | Q8NGQ2 | |
| LPPYIILRGTYIPPG | 411 | Q9P215 | |
| VYLLLPPALNPVVYG | 281 | Q8NH57 | |
| PLLLTQLPLLQPRYY | 926 | P29474 | |
| NLYLLIPPMLNPIIY | 281 | Q8NGF1 | |
| PPYLNENPLRALYLI | 441 | Q13177 | |
| SRPYPLPVQLPGILY | 501 | Q9P2N4 | |
| PYPGLSSVQPEELIY | 1471 | Q9P2K1 | |
| ILPQAPSGPSYAIYL | 511 | A0AVK6 | |
| PVLQSLYHRVLLYPP | 341 | Q5TH69 | |
| PPLPLESYIHNILYE | 221 | Q6ZUT9 | |
| QPAFPVQILPYLYLG | 241 | Q16829 | |
| LLPVILLPFYYTGVG | 241 | O43462 | |
| TADGYAPEYPLPLII | 216 | Q08554 | |
| AEPYKVYQLLPPGIV | 106 | Q00978 | |
| IATPPVYGQLLALYL | 31 | Q99627 | |
| IYINYNLPLVVLFPP | 571 | Q92674 | |
| YPQLRPGYIPIPVLH | 86 | O95817 | |
| LARPEALYYPGALLP | 76 | P20749 | |
| LNVLYGPDLPSIYPS | 326 | Q00888 | |
| LNVLYGPDLPRIYPS | 326 | P11464 | |
| ALLEYPEYSGPLLPA | 461 | Q969Z0 | |
| GILSYLADRPPPQYI | 111 | Q9UKN5 | |
| SYPVTLNVLYGPDLP | 321 | Q16557 | |
| LNVLYGPDLPRIYPS | 326 | Q16557 | |
| YLIIPPSLNPIIYGV | 281 | Q8NH60 | |
| ILYRLVPPALNPLVY | 296 | Q8NGH6 | |
| NFYLLIPPILNPIVY | 281 | Q8NGK5 | |
| YYGILDPPLIANGLI | 216 | P15428 | |
| QGLVLPYTYLDPPLI | 656 | O15296 | |
| YVIGPKIDIPLQYPG | 71 | Q75VX8 | |
| ALYAPLLPLPYGVSA | 241 | Q7Z736 | |
| LPRLSYPCILYGILP | 1841 | B5MCY1 | |
| IPSGYLELPDLGQPY | 446 | A0A087WUL8 | |
| IPSGYLELPDLGQPY | 1666 | A0A087WUL8 | |
| SYPVTLNVLYGPDLP | 321 | Q9UQ74 | |
| LNVLYGPDLPRIYPS | 326 | Q9UQ74 | |
| LNVLYGPDLPRIYPS | 326 | Q00887 | |
| PENEPLVLYIYGAPQ | 846 | P98174 | |
| LLFSVPPGYLRYTPE | 396 | Q7Z7L1 | |
| YQLPYQRVLPLPIFT | 81 | O15273 | |
| QTESPLLVRPYLPYI | 341 | Q9HAS3 | |
| LNVLYGPDLPRIYPS | 326 | Q13046 | |
| GITYRIPALLYIPPT | 21 | Q9UQ49 | |
| YPILLYPDIPQFCIP | 1276 | Q9BXT8 | |
| PLPFYEVYGELIRPT | 131 | Q9Y6X2 | |
| PPPVTYQGNLYRPLL | 836 | Q9H0D6 | |
| TPPAYINVLPGLPQY | 1331 | P53804 | |
| YPPLTYLEYPILIAQ | 61 | Q8N755 | |
| VLTYPLIGNYGIPPD | 51 | P27708 | |
| YGILVSLGYPIPKPD | 191 | A6NFI3 | |
| LVLPTPPYLFGILIQ | 1046 | O95405 | |
| LVSVNPYQELPLYGP | 46 | B0I1T2 | |
| PYQELPLYGPEAIAR | 51 | B0I1T2 |